|
Effectiveness and security of chronic hepatitis C treatment
in coinfected patients in real-world.
Uriarte-Pinto M, Navarro-Aznarez H, et al
Int J Clin Pharm.
2018 Mar 20.
Abstract
Successful treatment of HIV-/HCV-coinfected patients in the era of direct
acting antivirals: is advanced liver disease still a limiting factor?
Gonzales Zamora JA.
Infect Dis (Lond). 2017 Nov
12:1
Abstract
Eradication of HCV and non-liver-related non-AIDS-related events in HIV/HCV
coinfection.
Berenguer J, Rodríguez-Castellano E, Carrero A, et al
Hepatology. 2017 Jan 21..
Abstract
A molecular transmission network of recent hepatitis C infection in people with
and without HIV: Implications for targeted treatment strategies.
Bartlett SR, Wertheim JO, Bull RA, et al
J Viral Hepat.
2016 Nov 24.
Abstract
Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV
coinfection and HIV monoinfection.
Scherzer R, Heymsfield SB, Rimland D, et al
AIDS. 2016 Sep 24
Abstract
FULL-TEXT ARTICLE
Relationship of TRIM5 and TRIM22 polymorphisms with liver
disease and HCV clearance after antiviral therapy in HIV/HCV
coinfected patients.
Medrano LM, Rallón N, Berenguer J, et al
J Transl Med.
2016 Sep 2;14(1):257.
Paper
FULL-TEXT ARTICLE
Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and
HCV/HIV Co-Infection and Do Not Recover during Therapy.
Spaan M, Hullegie SJ, Beudeker BJ, Kreefft K,
et al
PLoS One.
2016 Jul 14;11(7):e0159243
Paper
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons
With HIV.
MacBrayne CE, Kiser JJ.
Clin Infect Dis. 2016 Jul 15;63
Suppl 1:S12-23.
Abstract
High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in
HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C, Grant J, Ammerman LR
J Antimicrob Chemother. 2016 Jun 20.
Abstract
Double Filtration Plasmapheresis in Treatment of Patients With Co-Infection
of Hepatitis C and Human Immunodeficiency Virus.
Mednikov RV, Rabinovich VI, Kizlo SN, et al
Ther Apher Dial. 2016
Apr 5.
Abstract
Modelling the impact of deferring HCV treatment on
liver-related complications in HIV coinfected men who have sex with men.
Zahnd C, Salazar-Vizcaya L, Dufour JF, et al
J Hepatol. 2016 Feb 24. pii:
S0168-8278(16)00164-1.
Abstract
Optimum combination therapy regimens for HIV/HCV infection.
Rey D, Muret P, Piroth L.
Expert Rev Anti Infect Ther.
2016 Jan 28.
Abstract
Current treatment options for hepatitis C patients co-infected with HIV.
Rockstroh JK, Hardy WD.
Expert Rev Gastroenterol Hepatol.2016
Jan 22. .
Abstract
Assessing liver disease in HIV-HCV coinfected patients.
Tsochatzis EA, Castera L.
Curr Opin HIV AIDS. 2014 Jun
30.
Abstract
Treatment of Hepatitis C in HIV-Infected Patients: Moving
Towards an Era of All Oral Regimens.
Chen TY, Jain MK.
AIDS Patient Care STDS. 2015
Jun;29(6):329-37.
Abstract
Liver-related death among HIV/hepatitis C virus-co-infected
individuals: implications for the era of directly acting antivirals.
Grint D, Peters L, Rockstroh JK, et al
AIDS. 2015 Apr 13.
Abstract
CROI 2015: Highlights of Viral Hepatitis Therapy.
Luetkemeyer AF, Wyles DL.
Top Antivir Med.
2015 Mar-Apr;23(1):66-76
Abstract
FULL-TEXT
ARTICLE
Treatment of chronic hepatitis C in patients with
HIV/HCV coinfection.
Coppola N, Martini S, Pisaturo M, et al
World J Virol. 2015 Feb
12;4(1):1-12
Paper
Influence of Treatment Complexity on Adherence and Incidence of Blips in
HIV/HCV Coinfected Patients.
Calvo-Cidoncha E, González-Bueno J,
Almeida-González CV, Morillo-Verdugo R.
J Manag Care Spec Pharm.
2015 Feb;21(2):153-7.
Abstract
Management of hepatitis C virus and human immunodeficiency
virus coinfection.
O'neil CR, Coffin CS.
Minerva Gastroenterol Dietol.
2014 Sep;60(3):165-175..
Abstract
Hepatitis C virus NS3 sequence diversity and antiviral resistance-associated
variant frequency in HCV/HIV coinfection.
Jabara CB, Hu F, Mollan K, et al
Antimicrob Agents Chemother.
2014 Aug 4.
Abstract
PPARγ2 Pro12Ala polymorphism is associated with sustained
virological response in HIV/HCV coinfected patients under HCV therapy.
Fernández-Rodríguez A, Berenguer J, Rallón N, et al"
J Acquir Immune Defic Syndr. 2014
Jul 26.
Abstract
Efficacy of lead-in silibinin and subsequent triple therapy
in difficult-to-treat HIV/hepatitis C virus-coinfected patients.
Braun D, Rauch A, Durisch N, et al
HIV Med. 2014 Jun 4.
Abstract
HIV/hepatitis C virus coinfection management: changing
guidelines and changing paradigms.
Cooper C, Klein M.
HIV Med.
2014 May 6..
Abstract
Spontaneous HCV clearance in HIV patients with chronic hepatitis C-bearing
IL28B-CC alleles using antiretroviral therapy.
Vispo E, Barreiro P, Plaza Z, et al
AIDS. 2014 Mar 15
Abstract
FULL-TEXT
ARTICLE
GB Virus C
infection in Patients With HIV/Hepatitis C Virus Coinfection: Improvement of
the Liver Function in Chronic Hepatitis C.
Feng Y, Liu L, Feng YM, et al
Hepat Mon. 2014 Mar 3;14(3):e14169.
Paper
Using patient-reported outcomes to improve the management of
co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.
Marcellin F, Roux P, Winnock M, Lions C, et al
Expert Rev Gastroenterol Hepatol.
2014 Mar 3..
Abstract
HCV and HIV co-infection: mechanisms and management.
Chen JY, Feeney ER, Chung RT.
Nat Rev Gastroenterol Hepatol.
2014 Feb 18.
Abstract
Treating HCV in HIV 2013: on the cusp of change.
Martel-Laferrière V,
Dieterich DT.
Liver Int. 2014 Feb;34 Suppl 1:53-9.
Abstract
Increased incidence of antiretroviral drug discontinuation
among patients with viremic hepatitis C virus coinfection and high
hyaluronic acid, a marker of liver fibrosis.
Grint D, Peters L, Rockstroh JK, et al
AIDS.
2014 Feb 20;28(4):577-87.
Abstract
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core:
Canadian guidelines for management and treatment of HIV/hepatitis C
coinfection in adults.
Hull M, Klein M, Shafran S, Tseng A,Can
J Infect Dis Med Microbiol.
2013 Winter;24(4):217-38.
Abstract
Re-treatment of chronic HCV infection in HIV co-infected
patients and predictors of sustained viral response.
Krastinova E, Bani-Sadr F, Fromentin D, et a
lInfect.
2013 Dec 27
Abstract
Strategies for assignment of HIV/HCV genotype 1-coinfected
patients to either dual-therapy or direct-acting antiviral agent based
triple therapy.
Mandorfer M, Neukam K, Rivero A, et al
Antivir Ther. 2013
Dec 17.
Abstract
Treatment of Genotype 1 HCV Infection in the HIV Coinfected
Patient in 2014.
Chastain CA, Naggie S.
Curr HIV/AIDS Rep.
2013 Nov 24
Abstract
Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV)
Infection in Human Immunodeficiency Virus Positive Patients.
Brown K, Labrie M, Coffin CS.
Curr HIV/AIDS Rep.
2013 Nov 21
Abstract
FULL-TEXT ARTICLE
Managing
HIV/hepatitis C co-infection in the era of direct acting antivirals.
Rockstroh JR, Bhagani S
BMC Med. 2013 Nov
1;11:234
.
Paper
Optimizing treatment in HIV/HCV coinfection.
Puoti M, Rossotti R, Travi G, Panzeri C,
et al
Dig Liver Dis. 2013 Sep
30;45S5:S355-S362.
Abstract
Changes in biomarkers of liver disease during successful combination
antiretroviral therapy in HIV/HCV-coinfected individuals.
Rohrbach J, Stickel F, Schmid P, et al
Antivir Ther.
2013 Sep 13.
.
Abstract
Effect of hepatitis C virus on immunological and virological
responses in HIV-infected patients initiating highly active
antiretroviral therapy: a meta-analysis.
Tsiara CG, Nikolopoulos GK, Dimou NL, et al
J Viral Hepat. 2013 Oct;20(10):715-24
Abstract
Therapy of chronic hepatitis C virus infection in the era of direct-acting
and host-targeting antiviral agents.
Conteduca V, Sansonno D, Russi S, et al
J Infect.
2013 Sep 3.
Abstract
Viral hepatitis and HIV: update and management.
Núñez M, Mendes-Correa MC.
Antivir Ther. 2013;18(3 Pt B):451-
Abstract
Current Management of Hepatitis C Virus Infection in Patients
With HIV Co-infection.
Sulkowski MS.
J Infect Dis. 2013 Mar;207 Suppl
1:S26-32.
Abstract |
General
Reports
Drugs
Documents
identified with this icon are in Portable Document Format (PDF) and require the
Adobe
Acrobat Reader